Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 19Terminated 5Recruiting 3Active not recruiting 3Withdrawn 2Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Hematologic Neoplasms 2Recurrence 1Older Patients 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1Graft vs Host Disease 1

Interventions

fludarabine 3Cyclophosphamide 3Busulfan 2venetoclax 1trametinib 1luspatercept 1gilteritinib 1dabrafenib 1Whole-Body Irradiation 1Vancomycin 1Thiotepa 1Teicoplanin 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Radiosurgery 1Ofloxacin 1NF protocol 1Mycophenolic Acid 1Metronidazole 1Meropenem 1Kidney Transplantation 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Cytarabine 1Complementary Therapies 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Hematologic Neoplasms × Busulfan × Clear all
NCT07524530 2026-06-05

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
98 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

NCT07441967 2026-03-02

The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting
44 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡